Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Rupesh Kumar Pati

Rupesh Kumar Pati

Indian Institute of Management Kozhikode, India

Title: Sustainability in healthcare for nation’s overall growth in developing and underdeveloped countries

Biography

Biography: Rupesh Kumar Pati

Abstract

The effect of industrializing has challenged the healthcare industry, where various new diseases like Anthrax, Bird flu, Ebola etc. Researches in these countries have found significant presence of expired drugs in Solid Waste Management (SWM). These pollute air, water and soil through incineration, seepage to river/water table and land filling. The exposure to these expired drugs (unknowingly) over a longer period negatively impact the immune system. The presence of large number of drug manufacturers (developing similar drugs under different brand) especially in developing nation (with less stricter regulations) allows flooding of drugs at retail/pharmacy. Hence, the need for effective disposal of large quantity of drugs (3-5% in India). The production of these excess drugs requires lot of water (as input) and discharging certain dangerous chemical byproducts. This leads to increased cost as-well-as pollution during production, transportation; and on expiry reverse logistics, disposal process. Hence, prices of drugs in the market are increased (as claimed by manufacturer during our focus group interaction). This increase makes the drug unaffordable to certain market segment/patients (especially in developing and under developed countries where Out of Pocket expenses are common) with poor public healthcare and insurance mechanism. All the above, challenges the basic business model of Healthcare sector on “sustainability framework” adversely affecting society, environment and economic of various stakeholders. The basic research question in this study is to provide inputs to policy formulation on: how to make the healthcare sector more sustainable: with easy accessibility of drugs at low cost (social), minimum wastages through expiry (environmental) and providing profit to the manufacturer to encourage him to invest in future needs?